Palbociclib-d8 is a deuterium labeled Palbociclib. Palbociclib is a selective and orally active CDK4 and CDK6 inhibitor with IC50s of 11 and 16 nM, respectively. Palbociclib has the potential for ER-positive and HER2-negative breast cancer research[1].
Molecular Weight:
455.58
Purity:
99.84
CAS Number:
[1628752-83-9]
Formula:
C24H21D8N7O2
Target:
CDK,Isotope-Labeled Compounds
Application Notes:
Isotope-Labeled Compounds
* VAT and and shipping costs not included. Errors and price changes excepted
